Hikal

14
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE475B01022
  • NSEID: HIKAL
  • BSEID: 524735
INR
243.55
-9.4 (-3.72%)
BSENSE

Dec 05

BSE+NSE Vol: 30.75 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Hikal Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
123.00
95.00
105.00
218.00
206.00
141.00
Adjustment
215.00
174.00
163.00
126.00
126.00
136.00
Changes In working Capital
-28.00
-53.00
75.00
18.00
-57.00
46.00
Cash Flow after changes in Working Capital
310.00
217.00
344.00
363.00
275.00
324.00
Cash Flow from Operating Activities
280.00
186.00
315.00
293.00
229.00
284.00
Cash Flow from Investing Activities
-136.00
-173.00
-292.00
-284.00
-156.00
-163.00
Cash Flow from Financing Activities
-143.00
-27.00
-7.00
-5.00
-96.00
-100.00
Net Cash Inflow / Outflow
0.00
-14.00
15.00
3.00
-24.00
20.00
Opening Cash & Cash Equivalents
12.00
26.00
11.00
7.00
31.00
11.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
13.00
12.00
26.00
11.00
7.00
31.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Hikal
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
123.8
154.59
-31.00
-19.92%
Adjustment
215.1
148.7
67.00
44.65%
Changes In working Capital
-28.7
-293.89
265.00
90.23%
Cash Flow after changes in Working Capital
310.2
9.4
301.00
3200.00%
Cash Flow from Operating Activities
280.4
-7.02
287.00
4094.30%
Cash Flow from Investing Activities
-136.5
-241.91
105.00
43.57%
Cash Flow from Financing Activities
-143.6
183.76
-326.00
-178.15%
Net Cash Inflow / Outflow
0.3
-65.17
65.00
100.46%
Opening Cash & Cash Equivalents
12.7
154.75
-142.00
-91.79%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
13
89.58
-76.00
-85.49%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 50.19% vs -40.79% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
280.40
186.70
50.19%